44
Nutrient Sensing, Acetyla2on, Mitochondrial Quality Control and Pathology Michael N. Sack Cardiovascular and Pulmonary Branch Na4onal Heart, Lung and Blood Ins4tute

2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Embed Size (px)

Citation preview

Page 1: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Nutrient  Sensing,  Acetyla2on,  Mitochondrial    Quality  Control  and  Pathology  

Michael  N.  Sack  Cardiovascular  and  Pulmonary  Branch  Na4onal  Heart,  Lung  and  Blood  Ins4tute  

   

Page 2: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Talk  Outline  

•  Caloric  Load,  Sirt3  and  the  Regula2on  of  Protein                Acetyla2on  •  Fas2ng  and  Tylenol  Liver  Toxicity    

•  Sirtuin  Biology  and  Mitochondrial  Quality  Control  •  The  Role  of  Fas2ng  and  Sirt3  on  NLRP3                Inflammasome  Biology  

Page 3: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Nutrient  excess,  obesity  and  disease  burden  

Malik  et  al,  Nat.  Rev.  Endocrinology  2013  

Page 4: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Nutrient  overload  orchestrate  growth  programing,    in  part,  via  protein  acetyla2on  and  glycosyla2on  

Wellen  and  Thompson,  Nature  Reviews  Mol.  Cell.  Biol.  2012  

Page 5: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Lysine  Acetyla2on:  an  emerging    post-­‐transla2onal  modifica2on  

Timeline        

1968-­‐acetyla4on  of  histones  discovered  

1997:  1st  non-­‐histone  acetylated  protein-­‐p53  

Before  2006:  <90  proteins  are  known  to  be  acetylated  

2006:  195  acetylated  proteins  (Kim  et  al.  Mol.  Cell)  

2009:  1750  acetylated  proteins  (Choudhary  et  al.  Science)  

2013:  >  2000  acetylated  proteins   133  mitochondrial  proteins  (195  total)    20%  of  mitochondrial  proteins  

Page 6: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Nutrient  availability  dependent  mitochondrial  protein  acetyla2on  

I  

Kendrick  et  al,  Biochem.  J.  2011  

High  Fat  Feeding  

Hepa2c  Mitochondrial  Proteins  

Fed/Fas2ng  Comparison  

Kim  et  al,  Molecular  Cell,  2006  

Page 7: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Acetyla2on  and  deacetyla2on  are    enzyma2cally  regulated  

ScoX  (2012)  Essays  Biochem.  

Page 8: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Sirtuins:  NAD+-­‐dependent  deacetylases  

Mammals  express  seven  Sirtuins  (Sirt  1-­‐7)  

Various  cellular  localiza2ons:  

Sirt1  &  2:  nuclear  and  cytosolic  Sirt3-­‐5:  mitochondrial  Sirt6  &  7:  nuclear  

 NAD+-­‐dependent  deacetyla2on  ADP  Ribosyla2on  ac2vity  (Sirt4  

&  6)      

Yang XJ et al, Nat Review Mol. Cell Biol. 2008;9:206-18

Page 9: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Sirt3  func2ons  as  the  nutrient-­‐sensi2ve    mitochondrial  lysine  deacetylase  

Hirschey  et  al,  Nature  (2010)  

Bao  J  et  al.  Free  Radical  Biol.  and  Med.  (2010)  

Lombard  et  al.  (2007)  Mol.  Biol.  Cell  

Page 10: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Recent fasting was more common than recent alcohol use among those who suffered hepatotoxicity after a dose of 4 to 10 g of acetaminophen per day (P=.02). Recent alcohol use was more common in the group who took more than 10 g/d than in those who took 4 to 10 g/d (P=.004). Conclusion: Acetaminophen hepatotoxicity after a dose of 4 to 10 g/d was associated with fasting and less commonly with alcohol use. Patients who developed hepatoxicity after taking acetaminophen doses of greater than 10 g/d for therapeutic purposes were alcohol users. Acetaminophen hepatotoxicity after an overdose appears to be enhanced by fasting in addition to alcohol ingestion.

Page 11: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Acetaminophen  toxic  metabolites  can  bind  to  lysine  residues  

   

Whether  this  plays  a  role  in  hepatotoxicity  is  unknown  

NAPQI  -­‐  N-­‐acetyl-­‐p-­‐benzoquine-­‐imine    

Page 12: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Hypothesis    

The  level  of  mitochondrial  protein  acetyla2on  modulates  suscep2bility  to  acetaminophen  

liver  injury    

This  may  be  mediated  in  part  by  modula2ng  NAPQI  binding  to  mitochondrial  proteins?  

Page 13: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

10 x WT 10 x KO

SIRT3  KO  mice  are  resistant  to    acetaminophen-­‐induced  liver  injury  

APAP 350mg/kg IP administration N-acetyl-p-aminophenol

SIRT3+/+ SIRT3-/-

*  

Page 14: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Iden2fica2on  and  characteriza2on  of    novel    substrates  of  SIRT3  in  the  murine  liver  

2D gel ko

2D gel wt

2D gel wt

2D gel

membrane

x-filmmembrane

x-filmmembraneblot

blot

stain

stain

cut spots

MS

2D gel ko

2D gel wt

2D gel wt

2D gel

membrane

x-filmmembrane

x-filmmembraneblot

blot

stain

stain

cut spots

MS

2D gel and MS to ID hyper-acetylated mitochondrial proteins

ID  poten2al  targets  

Page 15: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Representa2ve  2-­‐D  gels  employing  an  an2body  directed  against  acetylated  lysine-­‐residues  

1 2 3 4 5

6

7

8 9

10

11

12 13

14

150 75

25

kDa

pH 3 - 10

SIRT3+/+

SIRT3-/-

150 75

25

ALDH2

SIRT3+/+

SIRT3-/-

Ac- K

Page 16: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

ALDH2

Major  ALDH2  metabolic  pathways  

Catalyze the oxidation of aldehydes

Acetaldehyde

Acetate

NAD+

NADH

trans-4-hydroxy-2-nonenal (4-HNE)

Lipid peroxidation produces α,β-unsaturated hydroxyalkenal

Ethanol oxidation

Carboxylates

Page 17: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Mitochondrial  ALDH2  is  a  direct  target  of  the    toxic  acetaminophen  metabolite  -­‐  NAPQI  

Landin JS, et al. Toxicology and Applied Pharmacology 1996;141:299-307

Is this interaction integral to APAP hepatotoxicity?

Page 18: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

ALDH2  is  a  substrate  for  Sirt3  Deacetyla2on  

Page 19: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

ALDH2  func2on  is  preserved  in  fas2ng  Sirt3  KO    mice  

Page 20: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Hepa2c  shRNA  knockdown  of  ALDH2  negates  acetaminophen  ‘resilience’  in  SIRT3  -­‐/-­‐  mice  

Page 21: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Sirt3-­‐dependent  acetyla2on  status  modulates    NAPQI  binding  to  ALDH2  

Page 22: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Iden2fica2on  of  ALDH2-­‐  K377  as  the  func2onal  residue    for  NAPQI  binding

Page 23: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Iden2fica2on  of  an  allosteric  role  of  lysine  deacetyla2on  in  fas2ng  suscep2bility  to  acetaminophen  injury  

Lu  et  al.  EMBO  Reports  2011  

Page 24: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Talk  Outline  

•  Caloric  Load,  Sirt3  and  the  Regula2on  of  Protein                Acetyla2on  •  Fas2ng  and  Tylenol  Liver  Toxicity    

•  Sirtuin  Biology  and  Mitochondrial  Quality  Control  •  The  Role  of  Fas2ng  and  Sirt3  on  NLRP3                Inflammasome  Biology  

Page 25: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

SuXerwala  et  al.  (2014)  Ann  N  Y  Acad  Sci  

Inflammasome:  Mul4protein  intracellular  complex  that  sense  pathogen  /  damage  associated  molecular  paXerns  (PAMPS/DAMPs)  and  ac4vate  caspase-­‐1,  which  in  turn  cleaves/ac4vates  pro-­‐inflammatory  cytokines  IL-­‐1β  and  IL-­‐18.      

Defining  the  Inflammasome  Program  

NLRP  -­‐  Nod-­‐like  receptor  family  protein    ASC  -­‐    Adaptor  apoptosis-­‐associated  speck-­‐like                          protein  containing  a  CARD  and  pyrin  domain  (PYD)  

Page 26: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

SuXerwala  et  al.  (2014)  Ann  N  Y  Acad  Sci  

 NLRP3  Inflammasome:  -­‐  Mul4ple  triggers    (‘sterile  inflamma2on’)  –  

asthma,  atherosclerosis,  DM  and  aging  -­‐  Regulated  at  the  transcript  and  post-­‐transla4onal  

levels:    

Priming:  Transcrip4onal  induc4on  of  genes    encoding  components  of  the  NLRP3  complex.    Ac2va2on:  Complex  ac4va4on  by  stress-­‐signals  -­‐  ATP,  nigericin,  faXy  acids  &  cholesterol  crystals.    

1)  Priming:  LPS  

2)  Ac2va2on:    ATP  

The  NLRP3  Inflammasome  Program  

Page 27: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Mar2non,  Immunity  2012  

Mitochondrial  Disrup2on  as  a  Disease  Associated  Molecular  Pafern  (DAMP)  in  NLRP3  Ac2va2on  

Evolu2onary  endosymbionts      unmethylated  CpG  mo2fs    

(mito  rRNA  and  tRNA)  N-­‐formyl  pep2des    

     

Page 28: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx
Page 29: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Sirt1  and  Sirt3  Deacetylase  Enzymes  

Sack  MN  and  Finkel  T.    Cold  Spring  Harb  Perspect  Biol  2012  

Modulate  Mitochondrial  Func2on/Quality    (Caloric  Restric2on/Fas2ng)    

 

Page 30: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Can  Mitochondrial  Sirtuins  Regulate    the  NLRP3  Inflammasome?  

 Is  this  Dependent  on  the  

Modula2on  of  Mitochondrial  Homeostasis?  

Page 31: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Fas2ng  (caloric  restric2on  mime2c)  suppresses    the  NLRP3  inflammasome?  

F e d

F a s ted

0 .0

0 .5

1 .0

1 .5M o u s e p e rito n e a l m F

IL -1b

IL-1

b r

ele

as

e(r

ela

tiv

e t

o t

he

fe

d s

tate

)

*  There  is  a  40  %  decrease  in  the  release  of  IL-­‐1β  afer  fas4ng  

Page 32: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

NLRP3  ac2va2on  is  modulated  by  Sirt3  

*  Only  the  mitochondrial  sirtuin  Sirt3  appears  to  regulate  the  NLRP3  inflammasome  in  human  THP-­‐1  macrophages.  

And  in  mouse  in  vivo:  

WT

Sirt3 K

O

WT faste

d

Sirt3 K

O faste

d

0.5

1.0

1.5Mouse peritoneal mΦ

IL-1β

Cyt

okin

e re

leas

e(r

elat

ive

to th

e W

T)

*   +                +                +                +-­‐ +                -­‐ +

LPS

WT                    Sirt3  KO

ATP

CleavedCasp-­‐1

A B C

+                +                +                +-­‐ +                -­‐ +

LPS

WT                    Sirt3  KO

ATP

CleavedCasp-­‐1

A B C

+                +                +                +-­‐ +                -­‐ +

LPS

WT                    Sirt3  KO

ATP

CleavedCasp-­‐1

A B C

+                +                +                +-­‐ +                -­‐ +

LPS

WT                    Sirt3  KO

ATP

CleavedCasp-­‐1

A B C

+                +                +                +-­‐ +                -­‐ +

LPS

WT                    Sirt3  KO

ATP

CleavedCasp-­‐1

A B C

Sirt3

IL-­‐1β

NLRP3

ASC

Actin

-­‐ +                +                    -­‐ +                  +-­‐ -­‐ +                    -­‐ -­‐ +

LPS

WT                                              Sirt3  KO

ATP

A B C

Sirt3

IL-­‐1β

NLRP3

ASC

Actin

-­‐ +                +                    -­‐ +                  +-­‐ -­‐ +                    -­‐ -­‐ +

LPS

WT                                              Sirt3  KO

ATP

A B CFasted                                                  Fed

Sirt3

IL-­‐1β

NLRP3

ASC

Actin

-­‐ +                +                    -­‐ +                  +-­‐ -­‐ +                    -­‐ -­‐ +

LPS

WT                                              Sirt3  KO

ATP

A B CFasted                                                  Fed

C o n trol

+ Sir t

3

+ H/Y

mu ta

n t0 .0

0 .5

1 .0

1 .5 T H P -1

Cy

tok

ine

re

lea

se

(re

lati

ve

to

th

e c

on

tro

l)

*  

Page 33: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

The  role  of  Sirt3  in  NLRP3  inflammasome  regula2on  is  confirmed    in  Bone  Marrow  Derived  Macrophages

*  

Page 34: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Mitochondrial  Homeosta2c    Role  of  Sirt3  

Gira

lt    A  et  a

l.  Bioche

m  J,  201

2  

Improve  Energe2cs  Decrease  ROS  MPT  Resistance  

Diminished  Apoptosis  Enhanced  Mitophagy  

WT L

P S

WT L

P S + A

T P

S ir t3 K

O L

P S

S ir t3 K

O L

P S + A

T P

0

2

4

6

8

1 0

Cy

tos

olic

mtD

NA

(F

old

ch

an

ge

)

*  

U n t L P S + A T P R o te n o n e0

1

2

3

4

5

Mit

os

ox

in

ten

sit

y

S c rshRNAS ir t3shRNA

Page 35: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

The  counter-­‐regulatory  control  of    mitochondrial  protein  acetyla2on  

Sirt3  levels  are  increased  with  fas2ng  

Hirschey  et  al,  Nature  2010  

 Gcn5L1  levels  are  decreased  with  fas2ng  

Webster  B  et  al.  J.  Cell  Science  (2013)  

Sirt3

Gcn5L1

ScoX  I,  et  al.  Biochem  J.  2012  

Page 36: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Counter-­‐regulatory  roles  of  Gcn5L1  and  Sirt3  on  mitochondrial  acetyla2on  and  func2on  

ScoX  I,  et  al.  Biochem  J.  2012  

Mitochondrial  Protein  Acetyla2on  

Webster  B,  ScoX  I.  J  Cell  Sci  2013  

Modula2on  of  Mitophagy    

Page 37: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Gcn5L1  and  Sirt3  deple2on  have  counter-­‐regulatory  effects  on  the  NLRP3  inflammasome  

Traba  J,  et    al.  Unpublished  Data  

J774A.1  cells  

Page 38: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Mitochondrial  phenotype  in  J774A.1  macrophages  

Traba  J,  et    al.  Unpublished  Data  

Page 39: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

CLINICAL  RESEARCH  PROJECT        Protocol  #  14-­‐H-­‐0103                      

NHLBI  Protocol:  Pilot  Study  to  Evaluate  the  Effect  of  Fas5ng  on  the  NLRP3  Inflammasome    

Page 40: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

00 .1 1

0

1

2

3

4

5IL -1b

L P S (n g /m L )

Cy

tok

ine

re

lea

se

(re

lati

ve

to

th

e f

as

ted

sta

te)

F a s te d

F e d 1 h

F e d 3 h

0 .1 1

0 .8

1 .0

1 .2

1 .4 IL -1b

L P S (n g /m L )

Cy

tok

ine

re

lea

se

(re

lati

ve

to

th

e f

as

ted

sta

te)

F a s te d

F e d 1 h

F e d 3 h

Fas2ng  Blunts  the  NLRP3  inflammasome  in  Human  Subjects

Page 41: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Conclusions  

•       The  NLRP3  inflammasome  is  blunted  by  fas2ng    

•       NLRP3  inflammasome  ac2va2on  is  nutrient-­‐level  dependent            and  appears  to  be  modulated,  in  part,  by  the  Sirt3  -­‐Gcn5L1            regulatory  program    

•  Preliminary  data  suggest  that  that  fas2ng  and  the              mitochondrial  acetyla2on  regulatory  program  modifies            the  role  of  mitochondria  as  a  DAMP  in  NLRP3  ac2va2on    

•  This  nutrient-­‐sensing  program  is  opera2onal  in  healthy              human  subjects        

Page 42: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Mito  protein  

   SIRT3  

AC  

Ac  ↓  

GCN5L1  

Mitochondrial  Homeostasis  

↑  SIRT3  

Ac  Fas2ng  or  

CR  

Page 43: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Acknowledgements  

NHLBI  Laboratory  of  Mitochondrial  Biology  Kim  Han  

Shahin  Hassanzadeh  Javier  Traba  Komudi  Singh  Lingdi  Wang  Jing  Wu  Jessica  Li  

Miriam  Kwarteng-­‐Siaw    

Prior  Laboratory  Members  Zhongping  Lu  Iain  ScoX  

Brad  Webster    

NIAMS    Richard  Siegel  

 NHLBI  

Marjan  Gucek  Lance  Pohl  

   

Page 44: 2015-03-Final Bench to Bedside Talk - Revised - Shortened.pptx

Expert Opin. Drug Metab. Toxicol. (2008) 4(11)

NAPQI adducts covalently bind to cysteine residues on mitochondrial proteins contributing to hepatic

toxicity

NAPQI adducts increase The mass of a peptide by 149Da